BAX Baxter International stock outlook 2026. A qualitative look at the post-Vantive business mix, hospital capex sensitivity in Healthcare Systems & Technologies, competition from Fresenius, B. Braun and Becton Dickinson, the dividend track record, and the deleveraging story.
Alnylam Pharmaceuticals (ALNY) stock outlook 2026. A qualitative look at the RNAi/siRNA platform, the four-product commercial franchise, the Amvuttra opportunity in ATTR cardiomyopathy versus Pfizer's tafamidis and BridgeBio's acoramidis, the Novartis/Roche/Regeneron royalty model, nucresiran's late-stage trials, and the path to sustained profitability.
ZBH Zimmer Biomet stock outlook 2026. Comprehensive analysis of the knee and hip implant franchise, ROSA surgical robot competition against Stryker Mako, China VBP pricing pressure, and US investor tax strategy for this defensive medical device play.
Fiserv (NYSE: FI) stock analysis for 2026: Clover POS platform growth, merchant acquiring, bank core processing, competitive analysis vs. FIS and Global Payments, and tax treatment for US investors in Roth IRA and taxable accounts.
GPN Global Payments stock outlook 2026. Deep analysis of the Issuer Solutions separation strategy, merchant software moats, competition with Fiserv and FIS, and how US investors should think about this restructuring play.
MSCI Inc. stock analysis for 2026: index licensing AUM fees, ESG and analytics growth, competitive moat vs. FTSE Russell and S&P DJI, risk matrix, and US tax treatment for Roth IRA and taxable accounts.
Detailed analysis of GD (General Dynamics) stock for 2026: Columbia-class and Virginia-class submarine programs, Gulfstream business jets, GDIT defense IT, backlog fundamentals, and the case for defense sector investors.
Deep-dive into ICE (Intercontinental Exchange) stock for 2026: NYSE operations, Black Knight mortgage tech, fixed-income data infrastructure, energy futures, and the bull/bear case for long-term investors.
Comprehensive analysis of SPGI (S&P Global) stock for 2026: credit ratings moat, S&P 500 index licensing, Platts commodity data, IHS Markit integration, and what drives EPS growth for long-term investors.
In-depth analysis of TRV (Travelers Companies) stock for 2026: combined ratio fundamentals, hard market pricing, catastrophe reserves, dividend growth history, and the bull/bear case for US P&C insurance investors.
ETFs vs individual stocks: compare the pros, cons, risks, and time commitment. Includes a practical hybrid strategy that works for most investors in 2026.
Korea's ISA (Individual Savings Account) explained for 2026. Covers account types, tax-free limits, eligible investments, and how to open one as an expat.
401(k) vs IRA for 2026: contribution limits, tax benefits, employer matching, and investment options to find the right retirement strategy.
Start investing with as little as $100. This beginner's guide covers stocks, ETFs, index funds, and straightforward strategies to grow your money in 2026.
Learn how to place monthly dividend ETFs across Roth IRA, 401k, and taxable accounts to minimize taxes and maximize returns.